未登录

R

Robert P. Strosznajder

Polish Academy of Sciences

H指数:26

被引数:2,571

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metformin Induces Changes in Sphingosine-1-Phosphate-Related Signaling in Diabetic Mice Brain

二甲双胍诱导糖尿病小鼠脑内鞘氨醇-1-磷酸相关信号通路的变化

International Journal of Molecular Sciences

IF4.9

2026-03-030

OAAI

Fingolimod Improves Anxiety-like Behavior and Modulates Sphingosine-1-Phosphate Receptors Gene Expression in a Diabetic Mouse Model

芬戈莫德改善糖尿病小鼠模型中的焦虑样行为，并调节鞘氨醇-1-磷酸受体基因表达。

Biomolecules 2025, Vol. 15, Page 1485

IF0

2025-10-220

OAAI

Fingolimod Modulates the Gene Expression of Proteins Engaged in Inflammation and Amyloid-Beta Metabolism and Improves Exploratory and Anxiety-Like Behavior in Obese Mice

NEUROTHERAPEUTICS

IF6.9

2023-09-013

OAAI

Fingolimod exerts anxiolytic effect and upregulates genes involved in neuronal survival and amyloid beta metabolism in diabetic mice hippocampus

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2021-12-010

PRE

Age-Related Transcriptional Deregulation of Genes Coding Synaptic Proteins in Alzheimer's Disease Murine Model: Potential Neuroprotective Effect of Fingolimod

FRONTIERS IN MOLECULAR NEUROSCIENCE

IF3.8

2021-07-0913

OAAI

Fingolimod modulates genes expression of sphingosine-1-phoshate receptors and Sirt1 in diabetic mice brain

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2020-11-010

PREAI

Fingolimod modulates genes' expressions of sphingolipids metabolism enzymes and mitochondrial respiratory chain proteins in hippocampus of Alzheimer's transgenic mice

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2018-05-010

PREAI

Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2017-03-26182

OAAI

Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders

NEUROCHEMICAL RESEARCH

IF3.8

2016-11-24207

OAAI

Mechanism of amyloid beta peptides and alfa synuclein cytotoxicity. The role of PARPs and sirtuins. Implications in Alzheimer's disease

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-10-010

PREAI

The Lipoxygenases: Their Regulation and Implication in Alzheimer's Disease

NEUROCHEMICAL RESEARCH

IF3.8

2015-12-16109

OAAI

Sphingosine-1-phosphate: from regulation of gene expression to cytoprotection in an experimental model of neurodegenerative disorders

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2013-10-010

PREAI

The role of AIF and PARP in mitochondria nucleus cross talk in AD

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2013-10-010

PREAI

Expression and activity of PARP family members in the hippocampus during systemic inflammation: Their role in the regulation of prooxidative genes

NEUROCHEMISTRY INTERNATIONAL

IF4

2013-04-0128

PREAI

Evaluation of the antioxidative properties of lipoxygenase inhibitors

PHARMACOLOGICAL REPORTS

IF3.8

2012-09-0174

PREAI

Role of bioactive lipids and PARP-1 in neuronal cells death evoked by glucose deprivation stress

PHARMACOLOGICAL REPORTS

IF3.8

2011-09-010

PREAI

Inhibition of poly(ADP-ribose) polymerase-1 attenuates the toxicity of carbon tetrachloride

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2011-03-145

OAAI

Lipoxygenases and Poly(ADP-Ribose) Polymerase in Amyloid Beta Cytotoxicity

NEUROCHEMICAL RESEARCH

IF3.8

2011-02-0215

OAAI

Amyloid β(1-42) and its β(25-35) fragment induce activation and membrane translocation of cytosolic phospholipase A2 in bovine retina capillary pericytes

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

IF3.3

2004-11-0131

PREAI

Amyloid beta (AB) and a non AB component of Alzheimer disease amyloid (NAC) affect differently basic and receptors mediated nitric oxide synthase and poly(ADP-ribose) polymerase in hippocampus

NEUROBIOLOGY OF AGING

IF3.5

2004-07-010

PREAI